Innoventz, an eClinical solution provider, now offers its clients a no-risk study build on its next-generation clinical software, TrialBLAZER. The move reflects Innoventz’s commitment to solve the industry’s most pressing need, which is to find a cost-effective and robust eClinical solution that works specifically for the trial at hand. Both sponsors and contract research organizations (CROs) engage in marked risk when the burden is on them to evaluate, buy, learn, and configure a new platform. The risk can translate into increased costs, higher volume of down-time, and even a missed window to enter a market. However, with the TrialBLAZER no-risk study build, Innoventz is assuming the risk to help protect customers and also advance the quality of the clinical study for all involved. In so doing, Innoventz also strives to achieve a profitable, long-term win-win partnership with each customer.
“We have inverted the risk paradigm in the industry. EDC and CTMS providers typically demand that companies pay them training and hosting fees up front to learn their software often only to find that the software is not adequate or appropriate for the trial,” according to Osman Qamar, President of Innoventz. “Now, we are taking the risk by investing our time and hosting infrastructure to build and configure the study. Instead of a generic one to two-hour demo like those offered by other companies, our potential clients have the opportunity to fully evaluate the software configured for their actual study before paying us anything. We are extremely confident not just in our software but also in our ability to leverage our knowledge of the clinical process to configure and build studies.”
TrialBLAZER was created as a true solution that addresses why sponsors and clinical research organizations (CROs) struggle with their existing software: the pricing model, functionality, and the implementation paradigm of various software solutions. With TrialBLAZER, sponsors and CROs have the opportunity to perform user acceptance testing (UAT) on the Innoventz-configured study prior to payment. No fees are incurred until the study goes live, which can additionally save thousands of dollars per month as compared with other vendors.
End users such as site coordinators, monitors, and investigators also benefit. “With a typical industry platform, site coordinators log into the EDC, and if they are not enrolling a new subject, it is not clear where to go for open items such as missing forms,” said Mandy Howard, Innoventz Project Manager. “In contrast, our users like TrialBLAZER’s action item reports by role, which act as real-time to-do lists and a subject record view that provides a subject’s visit windows upon enrollment.”
Sponsors and CROs benefit from TrialBLAZER as well. Study homepage customization can be used for announcements, reminders, and tips to site users. Branding can be applied using sponsor or study logos and color schemes on every page. Innoventz can develop built-in custom study reports per client requirements.
Innoventz (innoventz.com) was founded in February 2004. Our introduction to the industry came as consultants working for medical device companies. In this capacity we worked with all major EDC platforms in the industry. We evolved into an eClinical company handling protocol analysis, study builds, data management, and monitoring. Building upon our technical background, we were able to implement innovative solutions on third party platforms. We came to recognize challenges facing sponsors and CROs in managing their EDC, CTMS, and ePRO systems along with integrating external data such as images and lab data for their clinical trials.